Brooklyn ImmunoTherapeutics slips ahead of corporate update

May 25, 2021 3:25 PM ETEterna Therapeutics Inc. (ERNA)By: Dulan Lokuwithana, SA News Editor1 Comment
  • Small-cap stock Brooklyn ImmunoTherapeutics (NASDAQ:BTX -13.8%) has shed more than a tenth of value so far. The company has scheduled a corporate update at 4:30 PM EST today.
  • A 13G filing submitted by Brooklyn ImmunoTherapeutics yesterday indicates an ownership position of ~11.4% held by John D. Halpern Revocable Trust and Warren Street Legacy, LLC based on 41.6M shares outstanding as of March 31.
  • After a sharp rise, Brooklyn ImmunoTherapeutics ended ~7.0% lower yesterday. The company announced the completion of $20M financing which it said would be used for the development of the mRNA gene editing and cell therapies technology.
  • Formed as a result of its merger with NTN Buzztime, the clinical-stage biopharmaceutical company has risen ~5.0% over the past 30-day period despite strong retail investor interest.

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.